The assessment of post-detoxification anhedonia: Influence of clinical and psychosocial variables

Substance Use and Misuse

Volumn 43, Issue 5, 2008, Pages 722-732

  Pozzi, Gino ^a   Martinotti, Giovanni ^a,b   Reina, Daniela ^a   Dario, Tiziana ^a   Frustaci, Alessandra ^a   Janiri, Luigi ^a   Bria, Pietro ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Anhedonia; BRMES; Cross sectional; EuropASI; SANS; SHAPS

Indexed keywords

ADULT; ANHEDONIA; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DETOXIFICATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRIORITY JOURNAL; SOCIAL PSYCHOLOGY; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; AFFECTIVE SYMPTOMS; ALCOHOLISM; COMORBIDITY; DEPRESSIVE DISORDER; EUROPE; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS;

EID: 41949104268     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/00952990701202954     Document Type: Article

References (31)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2. Andreasen, N. C. (1982). Negative symptoms of schizophrenia: Definition and reliability. Archives of General Psychiatry 39:784-788.
3. Andreasen, N. C. (1989). The Scale for Assessment of Negative Symptoms: Conceptual and theoretical foundations. British Journal of Psychiatry 155(Suppl. 7):49-58.
4. Bech, P., Rafaelsen, O. J. (1980). The use of rating scales exemplified by a comparison of the Hamilton and the Bech-Rafaelsen Melancholia Scale. Acta Psychiatrica Scandinavica 62(Suppl. 285):128-132.
5. Bersani, G., Orlandi, V., Gherardelli, S., Pancheri, P. (2002). Cannabis and neurological soft signs in schizophrenia: Absence of relationship and influence on psychopathology. Psychopathology 35:289-295.
6. Blanken, P., Hendriks, V., Pozzi, G., Tempesta, E., Hartgers, C., Koeter, M., et al. (1994). European Addiction Severity Index. A guide to training and administering EuropASI interviews. Bruxelles: COST Report.
7. Bovasso, G. B. (2001). Cannabis abuse as a risk factor for depressive symptoms. American Journal of Psychiatry 158:2033-2037.
8. Butler, S. F. (2004). The bath water or the baby? Addiction 99:413-414.
9. Conti, L. (2000). Repertorio delle Scale di valutazione in Psichiatria [A catalogue of the scales of evaluation in psychiatry]. Firenze: Società Editrice Europea.
10. Gawin, F. H., Ellinwood, E. H., Jr. (1988). Cocaine and other stimulants. Actions, abuse, and treatment. New England Journal of Medicine 318:1173-1182.
11. Heinz, A., Schmidt, L. G., Reischies, F. M. (1994). Anhedonia in schizophrenic, depressed, or alcohol dependent patients: Neurobiological correlates. Pharmacopsychiatry 27:7-10.
12. Janiri, L., Gobbi, G., Serretti, A., Mannelli, P., Pozzi, G., Tempesta, E. (1996). Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics. International Journal of Clinical Psychopharmacology 11:109-117.
13. Janiri, L., Martinotti, G., Dario, T., Reina, D., Paparello, F., Pozzi, G., et al. (2005). Anhedonia and substance-related symptoms in detoxified substance dependent subjects: A correlation study. Neuropsychobiology 52:37-44.
14. Klein, D. F. (1974). Endogenomorphic depression. Archives of General Psychiatry 31:447-454.
15. Koeter, M. W., Hartgers, C. (1997). Preliminary procedure for the computation of the EuropASI composite scores. Amsterdam: The Amsterdam Institute for Addiction Research.
16. Lampe, I. K., Kahn, R. S., Heeren, T. J. (2001). Apathy, anhedonia, and psychomotor retardation in elderly psychiatric patients and healthy elderly individuals. Journal of Geriatric Psychiatry and Neurology 14:11-16.
17. Loas, G. (1996). Vulnerability to depression: A model centered on anhedonia. Journal of Affective Disorders 41:39-53.
18. Loas, G., Pierson, A. (1989). Anhedonia in psychiatry: A review. Annales Medico Psychologiques (Paris) 147:705-717.
19. Mäkelä, K. (2004). Studies of the reliability and validity of the Addiction Severity Index. Addiction 99:398-410.
20. Marsden, J., Nizzoli, U., Corbelli, C., Margaron, H., Torres, M., Prada De Castro, I., et al. (2000). New European instruments for treatment outcome research: Reliability of the Maudsley Addiction Profile and treatment perceptions questionnaire in Italy, Spain and Portugal. European Addiction Research 6:115-122.
21. Martin-Soelch, C., Chevalley, A. F., Kunig, G., Missimer, J., Magyar, S., Mino, A., et al. (2001). Changes in reward-induced brain activation in opiate addicts. European Journal of Neuroscience 14:1360-1368.
22. McLellan, A. T., Cacciola, J. S., Alterman, A. I. (2004). The ASI as a still developing instrument: Response to Mäkelä. Addiction 99:411-412.
23. McLellan, T. A., Kushner, H., Metzger, D., Peters, R., Smith, L., Grissom, G., et al. (1992). The 5th edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 9:199-213.
24. Miller, N. S., Summers, G. L., Gold, M. (1993). Cocaine dependence: Alcohol and other drug dependence and withdrawal characteristics. Journal of Addictive Diseases 12:25-35.
25. Muller, M. J., Wetzel, H., Benkert, O. (2002). Differential effects of high-dose amisulpride versus flupentixol on latent dimensions of depressive and negative symptomatology in acute schizophrenia: An evaluation using confirmatory factor analysis. International Journal of Clinical Psychopharmacology 17:249-261.
26. Silver, H., Shlomo, N. (2002). Anhedonia and schizophrenia: How much is in the eye of the beholder? Comprehensive Psychiatry 43:65-68.
27. Snaith, R. P. (1993). Anhedonia: A neglected symptom of psychopathology. Psychological Medicine 23:957-966.
28. Snaith, R. P., Hamilton, M., Morley, S., Humayan, A., Hargreaves, D., Trigwell, P. (1995). A scale for the assessment of hedonic tone: The Snaith-Hamilton Pleasure Scale. British Journal of Psychiatry 167:99-103.
29. Stevens, A., Schwarz, J., Schwarz, B., Ruf, I., Kolter, T., Czekalla, J. (2002). Implicit and explicit learning in schizophrenics treated with olanzapine and with classic neuroleptics. Psychopharmacology (Berlin) 160:299-306.
30. Tollefson, G. D., Sanger, T. M. (1997). Negative symptoms: A path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine. American Journal of Psychiatry 154:466-474.
31. Willner, P. (1997). Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology 134:319-329.